Abstract
We take the opportunity here to expand on why we think this greater visibility is crucial and overdue. In particular, we want to describe how a particular focus on harmful product manufacturers, as a subsection within commercial actors, is worthy of inclusion as a meso-level influence. This is an area in which clear policy lever points, evidence and public opinion combine and have the potential for significant public health benefits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
